[LMB] AKICOT:L Comercials

Damien Sullivan phoenix at mindstalk.net
Wed Oct 20 03:04:24 BST 2021


On Tue, Oct 19, 2021 at 06:15:43PM +0000, Bujold list wrote:

> Ongoing Clinical Trials Will Decide Whether (or Not) Ivermectin Is Safe, Effective for COVID-19
> 
> https://www.factcheck.org/2021/09/scicheck-ongoing-clinical-trials-will-decide-whether-or-not-ivermectin-is-safe-effective-for-covid-19/
> 
> It may or may not work. Time will tell. Apparently some people here are already in possession of these results?

There have already been many such studies.  Quoting your own article:

"the National Institutes of Health counts over 70 studies evaluating the
safety and effectiveness of ivermectin to treat or prevent COVID-19 in
humans, the FDA says “currently available data do not show ivermectin is
effective against COVID-19,” "

"According to the preliminary results presented by Mills, the study
found no indication of benefit on the use of ivermectin — nor with
hydroxychloroquine or lopinavir-ritonavir, or metformin. The ivermectin
arm had 1,500 patients: 677 of them received a daily dose of the
medication, and 678 others were given a placebo, for three days."

"According to the results presented, 86 patients in the ivermectin group
required extended emergency room observation or hospitalization versus
95 in the placebo group. Both the differences in relative risk and
mortality relative risk between the two groups were not statistically
significant. These results have not been peer-reviewed yet."


So yeah, apparently two more trials are being done. But they're not being
done in a vaccum.  Ivermectin has already failed to show benefit in
multiple studies and real-world use; the smart money is that the new
trials will simply confirm that even more.


Also,

"One of the papers that increased the hope for ivermectin, which
included 400 people with symptoms of COVID-19, was retracted on July 14,
after concerns about plagiarism and inconsistencies in the data.
According to Nature, before being withdrawn, the paper was viewed more
than 150,000 times, cited more than 30 times and included in several
meta-analyses, creating a ripple effect of misinformation."

The case for ivermectin is built on sand.


More information about the Lois-Bujold mailing list